Heretofore, Campylobacter infections have been predominantly associated with gastrointestinal manifestations. Over the past two decades, an increasing number of case reports have suggested that the spectrum of disease is much broader. To date, only 10 cases of myocarditis/pericarditis in patients with C. fetus have been reported in the English literature out of which at least 4 patients have died. We describe here a further case to include as we review the literature.

Download full-text PDF

Source

Publication Analysis

Top Keywords

sepsis pericarditis
4
pericarditis caused
4
caused campylobacter
4
campylobacter fetus
4
fetus case
4
case report
4
report literature
4
literature review
4
review heretofore
4
heretofore campylobacter
4

Similar Publications

Background: Ventricular tachycardia (VT) in patients with cardiac sarcoidosis (CS) can lead to sudden cardiac death. The role of ventricular tachycardia ablation (VTA) in CS has been investigated in a few small, single-center, and larger observational studies, but the evidence still needs to be provided. This study aimed to investigate the clinical outcomes of VTA in patients with CS admitted with a diagnosis of VT.

View Article and Find Full Text PDF

Introduction: Purulent bacterial pericarditis is a potentially fatal disease with mortality rates reaching 100% if left untreated.

Case Presentation: We present the case of a 33-year-old Caucasian male patient who developed cardiac tamponade, most likely caused by a pyogenic liver abscess communicating with the pericardium. Treatment with antibiotics, extended sepsis therapy, and drainage of the abscess led to a full recovery.

View Article and Find Full Text PDF

Purulent pericarditis is rare condition in the modern era of antibiotics. However, it is a serious condition as it has an accelerated progression and is difficult to diagnose due to its nonspecific clinical presentation, resulting in high mortality. Herein, we present a case in which a 36-year-old male patient with otherwise unremarkable medical history developed abdominal sepsis complicated by purulent pericarditis post-appendectomy.

View Article and Find Full Text PDF

promising immunotherapeutic intervention for diseases.

Front Immunol

November 2024

Department of Cell, Development & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States.

Immunomodulating agents interact with the immune system and alter the outcome of specific immune processes. As our understanding of the immune system continues to evolve, there is a growing effort to identify agents with immunomodulating applications to use therapeutically to treat various diseases. (Mw), a heat-killed mycobacterium, is an atypical mycobacterial species that possesses strong immunomodulatory properties.

View Article and Find Full Text PDF

Proteomic Signatures of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Narrative Review.

Children (Basel)

September 2024

Infectious Diseases and Chemotherapy Research Laboratory, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.

Article Synopsis
  • MIS-C is a serious inflammatory condition in children linked to COVID-19, sharing symptoms with diseases like Kawasaki Disease and sepsis; however, the exact causes and distinct biomarkers for MIS-C remain unclear.
  • This study reviewed 15 previous research papers using proteomic methods, such as Mass Spectrometry, to analyze the serum/protein profiles of MIS-C patients, comparing them with other similar diseases and identifying differences.
  • While proteomic techniques show potential for revealing insights into MIS-C's mechanisms and identifying biomarkers, further studies are necessary to reliably differentiate MIS-C from its clinical counterparts.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!